scholarly article | Q13442814 |
P356 | DOI | 10.1161/01.CIR.0000027818.15792.1E |
P698 | PubMed publication ID | 12196333 |
P50 | author | David A. Bluemke | Q39818611 |
Bernhard L. Gerber | Q48868680 | ||
Joao A C Lima | Q90016233 | ||
Jérôme Garot | Q117253352 | ||
P2093 | author name string | Kathérine C Wu | |
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | myocardial infarction | Q12152 |
patient | Q181600 | ||
acute myocardial infarction | Q18558122 | ||
P304 | page(s) | 1083-1089 | |
P577 | publication date | 2002-08-01 | |
P1433 | published in | Circulation | Q578091 |
P1476 | title | Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction | |
P478 | volume | 106 |
Q26774810 | 25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future Perspectives |
Q36107225 | Advances in cardiac magnetic resonance imaging and computed tomography |
Q36971128 | Advances in clinical applications of cardiovascular magnetic resonance imaging |
Q57761241 | Animal Models of Tissue Characterization of Area at Risk, Edema and Fibrosis |
Q36031584 | Assessment of myocardial viability by cardiovascular magnetic resonance |
Q82638981 | Assessment of resting perfusion defects in patients with acute myocardial infarction: comparison of myocardial contrast echocardiography, combined first-pass/delayed contrast-enhanced magnetic resonance imaging and 99mTC-sestamibi SPECT |
Q27332462 | Association of subclinical atherosclerosis using carotid intima-media thickness, carotid plaque, and coronary calcium score with left ventricular dyssynchrony: the multi-ethnic Study of Atherosclerosis |
Q30497459 | Automated left ventricular diastolic function evaluation from phase-contrast cardiovascular magnetic resonance and comparison with Doppler echocardiography |
Q47191457 | C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction |
Q37195695 | Cardiac MR for the assessment of myocardial viability. |
Q36332864 | Cardiac imaging to identify patients at risk for developing heart failure after myocardial infarction |
Q34010261 | Cardiac magnetic resonance and computed tomography angiography for clinical imaging of stable coronary artery disease. Diagnostic classification and risk stratification |
Q43451890 | Cardiac magnetic resonance detection of left ventricular thrombus in acute myocardial infarction. |
Q37404896 | Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients |
Q35584601 | Cardiac magnetic resonance imaging: long term reproducibility of the late enhancement signal in patients with chronic coronary artery disease |
Q38336304 | Cardiac magnetic resonance in clinical cardiology |
Q79159329 | Cardiovascular magnetic resonance imaging |
Q39176820 | Cardiovascular magnetic resonance imaging assessment of outcomes in acute myocardial infarction |
Q42596294 | Characterizing Post-Myocardial Infarction Microvascular Obstruction by ECG: We Could Learn More From Cardiac Magnetic Resonance Imaging |
Q45073081 | Circumferential strain acquired by CMR early after acute myocardial infarction adds incremental predictive value to late gadolinium enhancement imaging to predict late myocardial remodeling and subsequent risk of sudden cardiac death |
Q35062046 | Clinical applications of cardiovascular magnetic resonance imaging |
Q48853427 | Clinical assessment of left ventricular rotation and strain: a novel approach for quantification of function in infarcted myocardium and its border zones |
Q35289460 | Collateral circulation formation determines the characteristic profiles of contrast-enhanced MRI in the infarcted myocardium of pigs. |
Q37398049 | Complementary prognostic values of stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance in patients with known or suspected coronary artery disease |
Q36457860 | Contrast agents and cardiac MR imaging of myocardial ischemia: from bench to bedside |
Q37074696 | Contrast-enhanced magnetic resonance imaging in the assessment of myocardial infarction and viability |
Q53626643 | Correction for partial volume errors in MR heart perfusion imaging. |
Q53545399 | Delayed contrast enhancement magnetic resonance imaging in congenital aortic stenosis. |
Q52954584 | Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. |
Q37424647 | Detection and characteristics of microvascular obstruction in reperfused acute myocardial infarction using an optimized protocol for contrast-enhanced cardiovascular magnetic resonance imaging |
Q35202297 | Determining microvascular obstruction and infarct size with steady-state free precession imaging cardiac MRI. |
Q30424619 | Diagnosis and management of ischemic cardiomyopathy: Role of cardiovascular magnetic resonance imaging |
Q36982543 | Diagnostic utility of cardiac magnetic resonance for detection of cardiac involvement in female carriers of Duchenne muscular dystrophy |
Q80625542 | Diagnostic value of late gadolinium-enhanced MRI and first-pass dynamic MRI for predicting functional recovery in patients after acute myocardial infarction |
Q26864740 | Distribution of late gadolinium enhancement in various types of cardiomyopathies: Significance in differential diagnosis, clinical features and prognosis |
Q34992842 | Dynamic changes of edema and late gadolinium enhancement after acute myocardial infarction and their relationship to functional recovery and salvage index |
Q35936957 | Early assessment of myocardial contractility by contrast-enhanced magnetic resonance (ceMRI) imaging after revascularization in acute myocardial infarction (AMI). |
Q30400325 | Early prediction of myocardial viability after acute myocardial infarction by two-dimensional speckle tracking imaging |
Q30408532 | Effect of microvascular obstruction and intramyocardial hemorrhage by CMR on LV remodeling and outcomes after myocardial infarction: a systematic review and meta-analysis |
Q57779416 | Flow-function relationships in chronic left-ventricular ischemic dysfunction: Impact of the transmurality of infarction |
Q53059774 | Focal brachial enhancement deficit: a normal anatomic variant? |
Q36070821 | Functional cardiac magnetic resonance imaging (MRI) in the assessment of myocardial viability and perfusion: an evidence-based analysis |
Q33604069 | HIV infection and abnormal regional ventricular function |
Q82992456 | Head to head comparison of quantitative versus visual analysis of contrast CMR in the setting of myocardial stunning after STEMI: implications on late systolic function and patient outcome |
Q43217779 | Impact of contrast material volume on quantitative assessment of reperfused acute myocardial infarction using delayed-enhancement 64-slice CT: experience in a porcine model |
Q93227475 | In Vivo Open- and Closed-chest Measurements of Left-Ventricular Myocardial Viscoelasticity using Lamb wave Dispersion Ultrasound Vibrometry (LDUV): A Feasibility Study |
Q30499540 | In vivo assessment of myocardial stiffness with acoustic radiation force impulse imaging |
Q39149965 | In-Vivo Assessment of Regional Mechanics Post-Myocardial Infarction: A Focus on the Road Ahead |
Q37345172 | Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction |
Q35027190 | Iron overload in polytransfused patients without heart failure is associated with subclinical alterations of systolic left ventricular function using cardiovascular magnetic resonance tagging |
Q37788872 | Ischaemic heart disease assessment by cardiovascular magnetic resonance imaging |
Q51235287 | Late gadolinium enhancement in the assessment of the infarcted mouse heart: a longitudinal comparison with manganese-enhanced MRI. |
Q96298511 | Left ventricular functional recovery of infarcted and remote myocardium after ST-segment elevation myocardial infarction (METOCARD-CNIC randomized clinical trial substudy) |
Q41569186 | Long-term left ventricular remodelling after revascularisation for ST-segment elevation myocardial infarction as assessed by cardiac magnetic resonance imaging |
Q30443794 | Longitudinal strain is a marker of microvascular obstruction and infarct size in patients with acute ST-segment elevation myocardial infarction |
Q79294238 | MR Imaging Evaluation of Myocardial Viability in the Setting of Equivocal SPECT Results with99mTc Sestamibi |
Q38099290 | MRI for acute chest pain: current state of the art. |
Q37812993 | MRI in acute myocardial infarction |
Q48723921 | Magnetic resonance imaging early after acute myocardial infarction. A visual analysis of myocardial perfusion based on a 17 segment model |
Q36582180 | Magnetic resonance imaging in patients with ICDs and pacemakers |
Q36052950 | Magnetic resonance imaging in the assessment of coronary artery disease |
Q44609211 | Magnetic resonance-derived circumferential strain provides a superior and incremental assessment of improvement in contractile function in patients early after ST-segment elevation myocardial infarction |
Q79920412 | Magnetocardiographic assessment of healed myocardial infarction |
Q38605332 | Microvascular obstruction after successful fibrinolytic therapy in acute myocardial infarction. Comparison of reteplase vs reteplase+abciximab: A cardiovascular magnetic resonance study |
Q37428313 | Molecular MRI of cardiomyocyte apoptosis with simultaneous delayed-enhancement MRI distinguishes apoptotic and necrotic myocytes in vivo: potential for midmyocardial salvage in acute ischemia |
Q46157020 | Multidetector-row computed tomographic evaluation of myocardial perfusion in reperfused chronic myocardial infarction: value of color-coded perfusion map in a porcine model |
Q41333072 | Myocardial Extracellular Volume Estimation by CMR Predicts Functional Recovery Following Acute MI. |
Q53573264 | Myocardial biopsy findings and gadolinium enhanced cardiovascular magnetic resonance in dilated cardiomyopathy. |
Q30441722 | Myocardial first-pass perfusion cardiovascular magnetic resonance: history, theory, and current state of the art. |
Q46316701 | Myocardial strain in sub-acute peri-infarct myocardium |
Q37907402 | Myocardial tagging by cardiovascular magnetic resonance: evolution of techniques--pulse sequences, analysis algorithms, and applications |
Q30483914 | Myocardial tissue tagging with cardiovascular magnetic resonance |
Q53643024 | Myocardial viability assessment by contrast-enhanced magnetic resonance imaging. |
Q51476311 | New automated Markov-Gibbs random field based framework for myocardial wall viability quantification on agent enhanced cardiac magnetic resonance images. |
Q37586251 | Non-invasive imaging of microvascular damage |
Q45180723 | Optimisation of strain rate imaging for application to stress echocardiography |
Q37417701 | Pathophysiology of coronary artery disease: the case for multiparametric imaging. |
Q41920674 | Percent infarct mapping for delayed contrast enhancement magnetic resonance imaging to quantify myocardial viability by Gd(DTPA). |
Q52980725 | Prediction of Infarct Transmurality From C-Reactive Protein Level and Mean Platelet Volume in Patients With ST-Elevation Myocardial Infarction: Comparison of the Predictive Values of Cardiac Enzymes. |
Q33912884 | Prediction of infarct severity from triiodothyronine levels in patients with ST-elevation myocardial infarction |
Q63976713 | Predictors of segmental myocardial functional recovery in patients after an acute ST-Elevation myocardial infarction |
Q30473748 | Prevalence of scarred and dysfunctional myocardium in patients with heart failure of ischaemic origin: a cardiovascular magnetic resonance study |
Q37945796 | Principles, current status and clinical implications of ischaemic heart disease assessment by cardiac magnetic resonance imaging |
Q36760564 | Prognosis following acute myocardial infarction: insights from cardiovascular magnetic resonance |
Q35090442 | Quantification of myocardial viability distribution with Gd(DTPA) bolus-enhanced, signal intensity-based percent infarct mapping |
Q82876391 | Quantitation of the thickness of the non-enhanced myocardial rim predicts recovery of territorial myocardial function in chronic ischemic heart disease: a cardiac magnetic resonance imaging study |
Q30458413 | Recent developments in non-invasive cardiology |
Q51407125 | Regional functional recovery after acute myocardial infarction: a cardiac magnetic resonance long-term study. |
Q36769403 | Regional myocardial microvascular dysfunction in cardiac amyloid light-chain amyloidosis: assessment with 3T cardiovascular magnetic resonance. |
Q41001981 | Relation of the ischaemic substrate to left ventricular remodelling by cardiac magnetic resonance at 1.5 T in rabbits |
Q34322273 | Relationship of dysglycemia to acute myocardial infarct size and cardiovascular outcome as determined by cardiovascular magnetic resonance |
Q51876709 | Robust assessment of the transmural extent of myocardial infarction in late gadolinium-enhanced MRI studies using appropriate angular and circumferential subdivision of the myocardium. |
Q86415712 | Role of Cardiac MRI in the Assessment of Cardiomyopathy |
Q36031580 | Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability. |
Q33812907 | Role of cardiovascular magnetic resonance in assessment of acute coronary syndrome |
Q48003421 | Role of first pass and delayed enhancement in assessment of segmental functional recovery after acute myocardial infarction |
Q51297181 | Salvage assessment with cardiac MRI following acute myocardial infarction underestimates potential for recovery of systolic strain. |
Q51969229 | Segmentation of non-viable myocardium in delayed enhancement magnetic resonance images. |
Q51960684 | Semi-automatic quantification of myocardial infarction from delayed contrast enhanced magnetic resonance imaging. |
Q30475158 | Single-Breathhold Four-Dimensional Assessment of Left Ventricular Morphological and Functional Parameters by Magnetic Resonance Imaging Using the VAST Technique. |
Q36304287 | Technology insight: assessment of myocardial viability by delayed-enhancement magnetic resonance imaging |
Q34305843 | The REFLO-STEMI trial comparing intracoronary adenosine, sodium nitroprusside and standard therapy for the attenuation of infarct size and microvascular obstruction during primary percutaneous coronary intervention: study protocol for a randomised c |
Q27014679 | The cardiac magnetic resonance (CMR) approach to assessing myocardial viability |
Q35548747 | The clinical impact of late gadolinium enhancement in Takotsubo cardiomyopathy: serial analysis of cardiovascular magnetic resonance images |
Q51539702 | The effect of intra-aortic balloon counterpulsation on left ventricular functional recovery early after acute myocardial infarction: a randomized experimental magnetic resonance imaging study. |
Q37000804 | The effect of microvascular obstruction and intramyocardial hemorrhage on contractile recovery in reperfused myocardial infarction: insights from cardiovascular magnetic resonance |
Q45011958 | The extent of myocardial damage assessed by contrast-enhanced MRI is a major determinant of N-BNP concentration after myocardial infarction |
Q36713426 | The role of noninvasive imaging in assessing hemodynamically significant coronary artery stenoses |
Q47216144 | Three-dimensional speckle tracking echocardiography for the evaluation of the infarct size and segmental transmural involvement in patients with acute myocardial infarction |
Q35989654 | Use of cardiac magnetic resonance to assess viability |
Q30479106 | Usefulness of two-dimensional strain echocardiography to predict segmental viability following acute myocardial infarction and optimization using bayesian logistic spatial modeling |
Q36462622 | Utility of Cardiac Magnetic Resonance to assess association between admission hyperglycemia and myocardial damage in patients with reperfused ST-segment elevation myocardial infarction |
Q53609367 | Visual estimation of the global myocardial extent of hyperenhancement on delayed contrast-enhanced MRI. |
Q58867648 | Why do we need magnetic resonance imaging in cardiology? |
Q80577070 | [Reliability of cardiac magnetic resonance imaging indicators of myocardial viability for predicting the recovery of systolic function after a first acute myocardial infarction with a patent culprit artery] |
Search more.